GenomeWeb News Tells MethylDetect’s Story And About Our New Studies

by MethylDetect | Jan 25, 2019 | Featured

MethylDetect Looks to Leverage High-Resolution Melt Tech for Oncology Assay Development   Full story at:...

MethylDetect’s Co-Founder A/Professor LL Hansen Invited To Give A Talk At 4BIO Summit: Europe

by MethylDetect | Nov 27, 2018 | Featured

qPCR & Digital PCR Congress, 27th-28th Nov 2018, Rotterdam, Netherlands EXPLORING ADVANCES IN TECHNOLOGY AND RESEARCH IN QPCR, DPCR/NGS, MICROFLUIDICS & GENE EDITING Talk title: Methylation-Sensitive High-Resolution Melting (MS-HRM) for sensitive DNA...

Our Assay Helps To Identify Cancer Predisposition – Lynch Syndrome

by MethylDetect | Nov 9, 2018 | News

MethylDetect’s assay targetting MLH1 gene is now a part of the NICE-mandated Lynch Syndrome pre-screen test. The results showing the performance of our MLH1 methylation testing assays, performed in collaboration with Sarah Cannon Molecular...

Proud To Be One Of The Finalists Of SCALE-UP Denmark National Finale 2018

by MethylDetect | Nov 1, 2018 | Featured

WHEN: 1 NOVEMBER 14.00-18.00 (2018) WHERE:  SAV VÆRKET, ÅRHUS, Søren Nymarks Vej 8A, 8270 Højbjerg FOR MORE...

MethylDetect’s CEO Tomasz K Wojdacz Invited To Give A Talk At High Tech Summit Powered By DTU (Technical University Of Denmark)

by MethylDetect | Sep 29, 2018 | Featured

Business Talk: “Molecular Biomarkers – a key to personalized medicine” by Tomasz K. Wojdacz, CEO, MethylDetect ApS in session: Biomarkers – The key to personalised health (Organised by Med Tech Innovation & Biopeople) for more info...